陰道藥物輸送的革新者

Callavid^® is at clinical stage for fertility and threatened miscarriage, with future applications in menopause, cancer, infectious diseases, and delivery of live biotherapeutics.

— As featured in —

患者需要創新的女性專用給藥系統來改善療效

Calla Lily Clinical Care' semi-automated machinery

嘉樂麗的新型陰道給藥設備已獲得專利，該設備擁有多項顯著優勢

“Callavid will be unbelievably popular with miscarriage patients as pessary leakage is the most frequent complaint, causing significant anxiety. The benefits of reducing psychological trauma, anxiety and depression are badly needed.”

Professor Siobhan Quenby

Director Biomedical Research Unit in Reproductive Health,
Professor of Obstetrics University of Warwick,
Deputy Director Tommy’s National Centre for Miscarriage Research,
Calla Lily Clinical Care Medical Advisor

The vagina’s huge medical potential has gone untapped, but not for much longer

“Calla Lily has developed a new leak-free vaginal drug delivery platform. It's simple to use (essential when patients have to administer medications themselves) and also helps to alleviate dosage anxiety and other stresses”

「多虧了英國國家健康與照顧卓越研究院（NICE）的新流產管理指南，我們現在第一次有推薦的藥物來幫助減少流產的發生率：陰道給藥微粉化黃體酮。嘉樂麗臨床護理的新設備解決了患者陰道給藥黃體酮治療中滲漏和不便等問題。」

Stuart Lavery 醫生

倫敦大學學院醫院（UCLH）女性健康部門臨床主任、嘉乐丽臨床護理醫學顧問

“This novel platform is of great benefit to anyone using a vaginally-delivered medication. By addressing the major issue of leakage, women can be assured the device delivers the correct dose in a convenient, tidy and less invasive fashion. It is truly a transformative device.”

Dr Kelle Moley

Former Deputy Director of Reproductive Health Technologies
at the Bill & Melinda Gates Foundation,
Calla Lily Clinical Care Medical Advisor